Table 3 Dissolution test results of artemether–lumefantrine samples (N = 74) collected from low and high malaria transmission settings in Uganda, June–December 2021
From: Pharmacopeial quality of artemether–lumefantrine anti-malarial agents in Uganda
Brand name | Artemether label claim (mg) | Number of samples tested n (%) | Artemether within pharmacopeial limit, 70% Pass/Fail | Lumefantrine within pharmacopeial limit, 60% Pass/Fail |
|---|---|---|---|---|
LONART | 20/120 | 20 (27%) | Pass | Pass |
40/240 | 1 (1.4%) | Pass | Pass | |
80/480 | 3 (4.1%) | Pass | Pass | |
LONART-DS | 80/480 | 1 (1.4%) | Pass | Pass |
ARTEFAN | 20/120 | 12 (16.2%) | Pass | Pass |
40/240 | 1 (1.4%) | Pass | Pass | |
60/360 | 1(1.4%) | Pass | Pass | |
80/480 | 1(1.4%) | Pass | Pass | |
LUMARTEM | 20/120 | 2 (2.7%) | Pass | Pass |
80/480 | 1 (1.4%) | Pass | Pass | |
CO-METHER | 20/120 | 5 (6.8%) | Pass | Pass |
KOMEFAN-140 | 20/120 | 1 (1.4%) | Pass | Pass |
COMBIART | 20/120 | 5 (6.8%) | Pass | Pass |
LUMERAX | 20/120 | 1 (1.4%) | Pass | Pass |
LARIACT | 20/120 | 3 (4.1%) | Pass | Pass |
Cach-ART | 20/120 | 2 (2.7%) | Pass | Pass |
LUMAREN | 20/120 | 2 (2.7%) | Pass | Pass |
COARTEM | 20/120 | 1 (1.4%) | Pass | Pass |
KOMEFAN | 20/120 | 1 (1.4%) | Pass | Pass |
LUMITER | 20/120 | 6 (8.1%) | Pass | Pass |
Not Indicateda | 20/120 | 4 (5.4%) | Pass | Pass |
Total number | 74 (100%) | 74 (100%) | 74(100%) | |